LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Pictilisib | 1.11 | uM | LJP6 | 3 | D21 | 72 | hr | 1657 | 2571 | 5505 | 0.4670 | 0.2373 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 1657 | 4873 | 5505 | 0.8851 | 0.8356 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 1657 | 5457 | 5505 | 0.9912 | 0.9874 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 1657 | 4826 | 5505 | 0.8766 | 0.8234 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 1 | O03 | 72 | hr | 1657 | 1842 | 5505 | 0.3346 | 0.0479 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 2 | O03 | 72 | hr | 1657 | 1946 | 5505 | 0.3535 | 0.0749 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 3 | O03 | 72 | hr | 1657 | 1960 | 5505 | 0.3560 | 0.0786 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 1 | O03 | 72 | hr | 1657 | 1922 | 5505 | 0.3491 | 0.0687 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 2 | O03 | 72 | hr | 1657 | 1924 | 5505 | 0.3495 | 0.0692 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 3 | O03 | 72 | hr | 1657 | 1837 | 5505 | 0.3337 | 0.0466 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 1 | E03 | 72 | hr | 1657 | 1192 | 5505 | 0.2165 | -0.1210 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 2 | E03 | 72 | hr | 1657 | 1274 | 5505 | 0.2314 | -0.0997 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 3 | E03 | 72 | hr | 1657 | 1199 | 5505 | 0.2178 | -0.1192 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 1 | C03 | 72 | hr | 1657 | 1204 | 5505 | 0.2187 | -0.1179 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 2 | C03 | 72 | hr | 1657 | 1362 | 5505 | 0.2474 | -0.0769 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 3 | C03 | 72 | hr | 1657 | 1533 | 5505 | 0.2784 | -0.0324 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1657 | 5134 | 5505 | 0.9325 | 0.9034 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1657 | 5390 | 5505 | 0.9790 | 0.9699 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1657 | 5142 | 5505 | 0.9340 | 0.9055 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 1657 | 1256 | 5505 | 0.2281 | -0.1044 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 1657 | 1192 | 5505 | 0.2165 | -0.1210 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 1657 | 1114 | 5505 | 0.2023 | -0.1413 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 1 | F21 | 72 | hr | 1657 | 3669 | 5505 | 0.6664 | 0.5227 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 2 | F21 | 72 | hr | 1657 | 3763 | 5505 | 0.6835 | 0.5471 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 3 | F21 | 72 | hr | 1657 | 4019 | 5505 | 0.7300 | 0.6136 |